Ozempic, Eliquis, Keytruda: The 9 top-selling drugs of 2024
Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...
Galderma enters fierce European atopic dermatitis market with Nemluvio approval
Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...
The Lancet1d
Patient in her 70s with COPD and asthma improving significantly since using monoclonal antibody dupilumab
Lyn Iemma, aged 75 years at the time of writing, would not describe her life as dramatic. Born and raised in Perth, WA, Australia, this thriving but relaxed city is the place she has always called ...
BioSpace3d
New M&A Action, BMS’ Ongoing Cost Cuts and the Insatiable Demand for Weight Loss Drugs
Novartis, Eli Lilly and more put on their deal-making caps, Bristol Myers Squibb targets $2 billion in savings through 2027, ...
MM&M4d
Mucinex dethrones Vicks as top Rx, OTC pharma brand for January
Mucinex knocked Vicks off the top spot for monthly TV ad impressions as pharma brands generated significant coverage from ...
Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.